Suppr超能文献

内质网中血红素降解导致的铁过载引发心肌缺血再灌注损伤中的铁死亡。

Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury.

作者信息

Miyamoto Hiroko Deguchi, Ikeda Masataka, Ide Tomomi, Tadokoro Tomonori, Furusawa Shun, Abe Ko, Ishimaru Kosei, Enzan Nobuyuki, Sada Masashi, Yamamoto Taishi, Matsushima Shouji, Koumura Tomoko, Yamada Ken-Ichi, Imai Hirotaka, Tsutsui Hiroyuki

机构信息

Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Division of Cardiovascular Medicine, Research Institute of Angiocardiology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

JACC Basic Transl Sci. 2022 Jul 27;7(8):800-819. doi: 10.1016/j.jacbts.2022.03.012. eCollection 2022 Aug.

Abstract

Ischemia-reperfusion (I/R) injury is a promising therapeutic target to improve clinical outcomes after acute myocardial infarction. Ferroptosis, triggered by iron overload and excessive lipid peroxides, is reportedly involved in I/R injury. However, its significance and mechanistic basis remain unclear. Here, we show that glutathione peroxidase 4 (GPx4), a key endogenous suppressor of ferroptosis, determines the susceptibility to myocardial I/R injury. Importantly, ferroptosis is a major mode of cell death in I/R injury, distinct from mitochondrial permeability transition (MPT)-driven necrosis. This suggests that the use of therapeutics targeting both modes is an effective strategy to further reduce the infarct size and thereby ameliorate cardiac remodeling after I/R injury. Furthermore, we demonstrate that heme oxygenase 1 up-regulation in response to hypoxia and hypoxia/reoxygenation degrades heme and thereby induces iron overload and ferroptosis in the endoplasmic reticulum (ER) of cardiomyocytes. Collectively, ferroptosis triggered by GPx4 reduction and iron overload in the ER is distinct from MPT-driven necrosis in both in vivo phenotype and in vitro mechanism for I/R injury. The use of therapeutics targeting ferroptosis in conjunction with cyclosporine A can be a promising strategy for I/R injury.

摘要

缺血再灌注(I/R)损伤是改善急性心肌梗死后临床结局的一个有前景的治疗靶点。据报道,由铁过载和过量脂质过氧化物引发的铁死亡参与了I/R损伤。然而,其意义和机制基础仍不清楚。在此,我们表明谷胱甘肽过氧化物酶4(GPx4)作为铁死亡的关键内源性抑制因子,决定了心肌对I/R损伤的易感性。重要的是,铁死亡是I/R损伤中细胞死亡的主要模式,不同于线粒体通透性转换(MPT)驱动的坏死。这表明使用针对这两种模式的治疗方法是进一步减小梗死面积从而改善I/R损伤后心脏重塑的有效策略。此外,我们证明缺氧和缺氧/复氧反应引起的血红素加氧酶1上调会降解血红素,从而在内质网(ER)中诱导铁过载和心肌细胞铁死亡。总体而言,由GPx4减少和内质网铁过载引发的铁死亡在I/R损伤的体内表型和体外机制方面均不同于MPT驱动的坏死。联合使用针对铁死亡的治疗方法和环孢素A可能是治疗I/R损伤的一种有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81c/9436815/f6afb48c75a9/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验